February 9, 2021 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Thermo Fisher Scientific Partners with Mindray on Clinical Chemistry Analyzers for use with Drugs of Abuse Immunoassays

Thermo Fisher Scientific Partners with Mindray on Clinical Chemistry Analyzers for use with Drugs of Abuse Immunoassays FREMONT, Calif., Feb. 9, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced a partnership with Mindray, a leading global developer, manufacturer and supplier of medical devices, to make available to customers two... Read more

February 8, 2021 M&A, Partnerships

MKS Instruments Makes Superior Offer to Acquire Coherent

Implied Value of Approximately $240 per Share, Transaction Value at $6 Billion Creates a global leader in photonics to accelerate customer solutions Offer represents 16% premium over implied value of Lumentum transaction Expected to be accretive to Non-GAAP earnings per share within 12 months of close Anticipated synergies of $180M within 36 months of close ANDOVER, Mass., Feb. 08, 2021 (GLOBE NEWSWIRE)... Read more

February 8, 2021 PAI Top-10 PR/Corporate

Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry. Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results Feb 08, 2021 4:01 PM EST AUSTIN, Texas, Feb. 8, 2021 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced results for its fourth quarter and full-year ended December 31,... Read more

February 8, 2021 Environ, Ag./Food & Bev PAI Top-10

Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle

SAN DIEGO–(BUSINESS WIRE)–Feb. 8, 2021 — Illumina, Inc. (NASDAQ: ILMN) has selected nine new genomics companies to join the second global funding cycle of Illumina Accelerator in the U.S. and UK. The global company creation engine, focused on partnering with entrepreneurs to build breakthrough genomics startups, invested in four companies for the second funding cycle... Read more

February 8, 2021 Clinical Research/Diagn. Lab Top-10 Liq. Handling & Robotics Product Launch

Thermo Fisher Scientific Launches CE-IVD-Marked High Throughput COVID-19 Diagnostic Assay for Use On Its Automated Amplitude Platform

Thermo Fisher Scientific Launches CE-IVD-Marked High Throughput COVID-19 Diagnostic Assay for Use On Its Automated Amplitude Platform Applied Biosystems TaqPath COVID-19 High Throughput Combo Kit also receives Interim Order Authorization from Health Canada CARLSBAD, Calif., Feb. 8, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today launched its CE-IVD-Marked, Applied Biosystems TaqPath... Read more

February 8, 2021 Acad, Gov/Utilities

FDA grants Breakthrough Device Designation for Roche's Elecsys Growth Differentiation Factor-15 (GDF-15) assay to help identify patients suitable for innovative treatment addressing unintentional weight loss in cancer patients

FDA BDD acknowledges the importance of GDF-15 testing in identifying eligible cachexic patients with solid tumours to be treated with Pfizer’s investigational drug PF-06946860 Unintentional weight loss (cachexia) is a highly prevalent complication of cancer, affecting more than half of all cancer patients worldwide, potentially leading to significant functional impairment and increased risk of death... Read more

February 5, 2021 PR/Corporate Product Launch

Pacific Biosciences Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 100,000 shares of... Read more

February 5, 2021 PR/Corporate Product Launch

Pacific Biosciences Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 100,000 shares of... Read more